2023年6月5日

顶点集团继续支持美国癌症协会BrightEdge先端集团有限公司,全球金融服务提供商,已经宣布其职权范围扩大到支持的投资和风险投资机构的影响美国癌症协会。BrightEdge ACS影响风险投资基金盈利早期公司正在开发尖端cancer-focused治疗,诊断设备,和技术给所有人机会去检测,治疗和癌症生存。产生财务回报的投资将再投资基金和/或返回ACS作为ACS的多样化和可持续的资金来源的降低癌症死亡率的使命,结束痛苦,和促进卫生公平。顶点集团最初在2022年任命BrightEdge提供基金管理服务,使BrightEdge与一个健壮的、高效的服务模型操作,释放资源,重点部署支持ACS的资本和企业创收目标的影响。ACS的使命的坚定支持者,先端集团已承诺很大比例的费用收入收到其作为基金管理人的基金,作为ACS进行捐赠。迈克尔Carrillo顶点集团还将提供与环境、社会和治理评级BrightEdge &报告服务以及其影响积极的解决方案。顶点集团的环境、社会和治理评级&报告解决方案于2019年发射升空,至今超过400个GPs使用&有限合伙人和2000 +投资组合公司在50多个国家。正解的影响,在2022年推出的顶点集团的环境、社会和治理影响月提供最全面的影响评估服务的私人市场,让投资者和企业展示有意义的和可衡量的积极影响与完整性。顶点集团很高兴参与BrightEdge大会5月30日在纽约举行的主题动员和环境、社会和治理市场对癌症的影响。首席创新官乔治·阿奇博尔德和地区董事总经理,美洲,加入了一个专家小组讨论的影响和环境、社会和治理标准和框架——挑战和机遇的。 Georges Archibald, Chief Innovations Officer and Regional Managing Director, Americas comments: “We are proud to be further supporting the mission of the ACS – to defeat cancer and advance health equity for all – with our innovative ESG and Impact Ratings & Reporting Solutions. Measuring the impact of investment can be a complex and multi-faceted undertaking with a range of qualitative and quantitative data needed to form a comprehensive assessment.” Michael Carrillo, Director, Client Strategy & Relations, Apex Group further comments: “The expansion of our mandate with BrightEdge is testament to our strong emphasis on client support and the ability to tailor the right solutions for their needs. We are excited for this opportunity to further service BrightEdge as they drive positive change through their important work.” Alice L. Pomponio, Managing Director, BrightEdge further comments: “We are delighted to continue and expand our relationship with Apex Group, which offers key services in support of BrightEdge, the Fund, and our unique and proprietary Cancer Impact Investing FrameworkTM .”